Alyssum Therapeutics

Developer of supramolecular therapeutics designed for cancer patients. The company offers treatments and antibody drugs to treat lung, testicular, colorectal, and childhood cancers, its therapeutics u...

Healthcare
Cambridge, MA, United States
Founded 2011
4 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$32.7M
Last Round
N/A

Get the full picture

Create a free account to unlock Alyssum Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required